Search results
1st Source (SRCE) Upgraded to Strong Buy: Here's Why
Zacks via Yahoo Finance· 1 hour ago1st Source (SRCE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Enhancing Supply Chain Visibility: Info-Tech Research Group Publishes Insights on Control Tower...
WROC Rochester· 2 hours agoManufacturers are witnessing operational transformations, efficiency gains, and improved customer...
This high schooler won $10,000 because he saw a mysterious outbreak killing sea turtles in his...
Business Insider via Yahoo News· 43 minutes agoBut he was denied. Determined not to give up, he set out to find a non-invasive way to conduct his ...
Sociedad Quimica (SQM) Earnings and Sales Top Estimates in Q1
Zacks via Yahoo Finance· 1 hour agoPrice Performance Shares of Sociedad Quimica are down 26.4% over a year compared with the industry’s...
If You'd Invested $1,000 in the Stock Market 5 Years Ago, Here's What You'd Have Today
The Motley Fool via AOL· 43 minutes agoImage source: The Motley Fool/Upsplash You'll often hear that the key to growing wealth, whether for...
Jacobs (J) to Support Hertfordshire's Infrastructure Upgrade
Zacks via Yahoo Finance· 2 hours agoThe backlog in the Critical Mission Solutions segment was $8.45 billion, up from $8.14 billion a...
State opens first-of-its-kind energy research and demonstration facility that could revolutionize...
The Cool Down via Yahoo News· 7 hours agoHydrogen is going through an intense vetting process in Texas that is intended to prove the fuel ...
United Rentals (URI) Down 3.5% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 hours agoIf you aren't focused on one strategy, this score is the one you should be interested in. Outlook...
Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday
Zacks via Yahoo Finance· 2 hours agoHowever, no such deals materialized as Novartis reportedly dropped out of the race. Year to date,...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 1 hour agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...